Novartis Investigative Site

Klaipėda, LTU LT-93220

0 studies enrolling now · 3 studies all time

What they study most

Asthma, Atherosclerosis, Moderate to Severe Plaque-type Psoriasis

Studies at this site

• Study of Efficacy and Safety of QAW039 in Patients With Severe Asthma Inadequately Controlled With Standard of Care Asthma Treatment. — Completed
• Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events) — Completed
• Extension Study of Secukinumab Prefilled Syringes in Subjects With Moderate to Severe Chronic Plaque-type Psoriasis Completing Preceding Psoriasis Phase III Studies With Secukinumab — Completed